Event Date/Time: Feb 09, 2004
End Date/Time: Feb 11, 2004
IBC’s 2nd Annual Biomarkers will examine the tremendous potential for the parallel analysis technologies that interrogate transcript, protein and metabolites to define biomarkers for the diagnosis of disease and its progression, as well as the safety and efficacy of drugs in development. This is the only event where you will gain first-hand insight on the application of these tools, how the results are being validates and considerations for commercialization. The following pioneers in academia, industry and government agencies will share data founded in recent efforts: Stanley A. Hefta, Ph.D., Bristol-Myers Squibb; Lance Liotta, Ph.D., NCI, NIH; Karol Sikora, Ph.D., Hammersmith Hospital; Kathryn C. Zoon, Ph.D., NCI, NIH; Samir Hanash, Ph.D., University of Michigan; and Sudhir Srivastava, Ph.D., NCI, NIH.